eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications
Eclampsia: Follow-up
Updated: Apr 1, 2009
Follow-up
Further Inpatient Care
Continue to monitor blood pressure, neurologic status, and urine output until the patient is stable after delivery. Patients may require antihypertensive therapy after delivery and hospital discharge.
Further Outpatient Care
Follow up 1-2 weeks after delivery to evaluate for blood pressure control and any residual deficits from the eclamptic seizure. Patients with persistent hypertension past 8 weeks' puerperium or neurologic changes may need medical referral.
Inpatient & Outpatient Medications
This disease is treated on an inpatient basis, as described above. Outpatient care plays no role in management.
Transfer
Eclampsia clearly poses a risk of considerable maternal and neonatal morbidity and mortality. Patients with eclampsia may benefit from management at a tertiary care center.
Deterrence/Prevention
- Routine prenatal care
- Early diagnosis and aggressive management of preeclampsia
Complications
- As many as 56% of patients with eclampsia may have transient deficits, including cortical blindness.
- Studies have failed to demonstrate evidence of persisting neurologic deficits after uncomplicated eclamptic seizures during the follow-up period.6
- Maternal, as well as fetal, death can be a consequence of eclampsia and its complications.
Prognosis
- About 25% of women with eclampsia have hypertension in subsequent pregnancies.
- 5% of patients with hypertension develop severe preeclampsia.
- About 2% of women with eclampsia develop eclampsia with future pregnancies.
- Multiparous women with eclampsia have the following:
- A higher risk for development of essential hypertension
- A higher mortality rate in subsequent pregnancies as compared with primiparous women
Patient Education
- The patient should be advised and educated on the course of the disease and any residual problems.
- The patient should be educated on the importance of adequate prenatal care in subsequent pregnancies.
- If the patient has preexisting hypertension, she should have good control prior to conception and throughout pregnancy. Her case should be followed for recognition and treatment of preeclampsia.
Miscellaneous
Medicolegal Pitfalls
- The mode of delivery should be based on obstetric indications, with the understanding that vaginal delivery is preferable from a maternal standpoint.
- When emergent cesarean delivery is indicated, substantiating the absence of DIC prior to the procedure is important.
- Fetal bradycardia is common following an eclamptic seizure and usually resolves within 10 minutes. Consider placental abruption if uterine hyperactivity remains and fetal bradycardia persists.
- Cervical examination should not be overlooked. The delivery mode may be largely dependent on the cervical status.
- Fluid management is critical in patients with eclampsia.
- Avoid the use of multiple agents, unless necessary, to abate eclamptic seizures.
- Ruling out eclampsia in an obstetrical patient who has been involved in an unexplained trauma is important.
Special Concerns
- Do not overlook other neurologic causes, particularly if the seizure occurs more than 24 hours after delivery.
- When preeclampsia occurs in the early second trimester (ie, 14-20 weeks' gestation), the diagnosis of hydatiform mole or choriocarcinoma should be considered.
- Eclampsia always should be considered in a pregnant patient with a seizure episode.
- A pregnant patient who has been involved in an unexplained trauma (such as a single-vehicle auto accident) and has exhibited seizure activity should be evaluated for eclampsia.
The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors Stephanie R Fugate, DO and coauthor Gregory E Chow, MD to the development and writing of this article.
More on Eclampsia |
| Overview: Eclampsia |
| Differential Diagnoses & Workup: Eclampsia |
| Treatment & Medication: Eclampsia |
Follow-up: Eclampsia |
| References |
| « Previous Page |
References
Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. Nov 26 1994;309(6966):1395-400. [Medline].
Mattar, F, Sibai BM. Eclampsia. VIII. Risk Factors for maternal morbidity. Am J Obstet Gynecol. 1990;163:1049-55.
Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22(2):203-12. [Medline].
Sahin, G. Incidence, morbidity and mortality of pre-eclampsia and eclampsia. Available at www.gfmer.ch/Endo/Course2003/eclampsia.htm. Accessed February 18, 2009.
Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. Feb 2005;105(2):402-10. [Medline].
Sibai BM, Sarinoglu C, Mercer BM. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol. Jun 1992;166(6 Pt 1):1757-61; discussion 1761-3. [Medline].
MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. Apr 2001;97(4):533-8. [Medline].
Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. Jul 27 1995;333(4):201-5. [Medline].
Further Reading
Keywords
eclampsia, seizures in pregnancy, toxemia of pregnancy, coma in pregnancy, preeclampsia, cerebral vasospasm, focal ischemia, hypertensive encephalopathy
Follow-up: Eclampsia